Multiple Sclerosis Research to Practice I: Neuropathology and Biomarkers

September 14, 2020
1:00-2:00pm ET

Multiple Sclerosis Research to Practice I: Neuropathology and Biomarkers

Jointly provided by Consortium of Multiple Sclerosis Centers and PlatformQ Health Education, LLC

Credit Available

  • Physicians— maximum of 1 AMA PRA Category 1 Credit(s)
  • Nurses— 1 Nursing Contact Hours
  • Pharmacists— 1 Contact Hours (0.1 CEUs)


This activity is supported by educational grants from Biogen, Genentech, and Sanofi Genzyme.

Target Audience

Neurologists, primary care physicians, advance practice clinicians, nursing professionals, pharmacists, and other healthcare professionals involved in the care of patients with MS.

Learning Objectives

  • Summarize biomarkers in MS and their role in making treatment decisions
  • Examine how biomarkers may be associated with disease development and progression, differences in patient symptoms, and response to treatment

Accreditation Information

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC), and Platform Q Health Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Ellen M. Mowry, MD
Professor of Neurology and Epidemiology
Johns Hopkins University

Daniel Ontaneda, MD, MSc
Associate Professor of Neurology
Cleveland Clinic Lerner College of Medicine of Case Western
Reserve University

About Me

The Continuing Medical Education Program is an integral part of the organization’s overall mission which aims to improve learners’ competence and performance‐in‐practice and ultimately improve patient outcomes.

Related Posts